Atrial Fibrillation Ablation in Heart Failure: Difference in 3-Year Outcomes between Reduced and Preserved Ejection Fraction
Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). The coexistence of these conditions can further induce structural changes and result in worsened outcomes such as stroke, HF decompensation, poorly controlled AF, and mortality [1]. Catheter ablation of AF has been proven to be an effective therapeutic option for AF management in HF, particularly in heart failure with reduced ejection fraction (HFrEF) [2, 3]. However, the real-world data on the impact of AF ablation in heart failure with preserved ejection fraction (HFpEF) is not well-established.
